Galenica Sustainability and Business Performance
About Galenica
Market environment
Business performance
Governance
Local Pharmacies: growth in line with market development
Net sales (in million CHF)
1'262
+1.8%
617
628
2021
H1 2021
H1 2022
Expansion effect
+2.9%
+1.0%
08.08.2022
1 Impact of COVID-19 initiatives includes net sales of PCR tests, Rapid Antigen tests, self-tests as well as vaccinations
51
Sustainability
Outlook
Key developments
High demand for cough
and cold medications
Increasing footfall at
high-frequency
locations
Negative growth impact of
COVID-19 Initiatives¹)
-5.7%
Triofan
VERFORA
Triofan
Spin
Algifor
Liquid caps 400
Ibuprofen 400 mg
Schmerzmittel
mit entzündungstemmender
and teberserkerder Wirkung
10 Weichgelainkan
VERFORA
VICKS
VICKS
VapoRub
VICKS
VapoRub
Sale Onguent
AMAVITA+BAHNHOF APOTHEKE
SARS-CoV-2 Rapid Antigen Test
SARS-CoV-2 Rapid Antigen Test
25
SARS-CoV-2 Rapid Antigen Test
SARS-Col-2 Rapid Antigen Test
MORGENC
GALENICAView entire presentation